Biogen (BIIB) Restructuring Costs (2010 - 2026)
Biogen (BIIB) posted Restructuring Costs of $165.4 million for Q2 2026, compared with -$700,000 a year earlier.
Powered by 
Analysis
Biogen (BIIB) Restructuring Costs (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Restructuring Costs at Biogen was $187.3 million, up 301.1% year-over-year; for FY2025, it was $48.6 million, up 60.9% from FY2024.
- Annual Restructuring Costs shows a three-year compound annual growth rate of -28.2% (FY2022 to FY2025).
- In prior years, Biogen's Restructuring Costs was $30.2 million in FY2024 (-86.2%), $218.8 million in FY2023 (+66.9%) and $131.1 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Restructuring Costs in data going back to Q4 2010.
- On a year-over-year basis, Restructuring Costs increased in three of the last six quarters, with an average decline of 3.8%.
- The strongest year-over-year quarter for Restructuring Costs in the past five years was Q3 2023, with growth of 393.5%; the weakest was Q4 2024, with a decline of 94.6%.
- According to Business Quant data, Restructuring Costs for the three prior quarters was $7.9 million (Q1 2026), $6.6 million (Q4 2025) and $7.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.40 Mn |
| Mar 31, 2026 | 7.90 Mn |
| Dec 31, 2025 | 6.60 Mn |
| Sep 30, 2025 | 7.40 Mn |
| Jun 30, 2025 | -700,000.00 |
| Mar 31, 2025 | 35.30 Mn |
| Dec 31, 2024 | 5.30 Mn |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | 11.50 Mn |
| Dec 31, 2023 | 98.80 Mn |
| Sep 30, 2023 | 76.00 Mn |
| Jun 30, 2023 | 34.40 Mn |
| Mar 31, 2023 | 9.60 Mn |
| Dec 31, 2022 | 7.00 Mn |
| Sep 30, 2022 | 15.40 Mn |
| Jun 30, 2022 | 70.60 Mn |
| Mar 31, 2022 | 38.10 Mn |
| Sep 30, 2019 | 300,000.00 |
| Jun 30, 2019 | 800,000.00 |
API Access
Biogen Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();